Jeuveau is a form of purified botulinum toxin type A called prabotulinumtoxinA and was first introduced in the United States in 2019. Jeuveau, like other toxins within this class, is FDA-approved for treating fine lines and wrinkles but is the only neurotoxin approved exclusively for cosmetic use. While all neuromodulators within the botulinum toxin family contain exclusive formulas and have similar safety profiles, Jeuveau's claim to fame is its manufacturing and refinement process, which many believe contributes to the product's superior success and satisfaction amongst patients. Jeuveau employs a manufacturing purification process utilizing Hi-Pure technology that produces a highly purified form of botulinum toxin that prevents neurotransmitters from binding to their receptors, thereby relaxing underlying facial muscles responsible for causing wrinkles. Jeuveau is also the most precise neurotoxin with regard to diffusion. This is critical as it dictates where and how the injectable product is placed within the muscle. Another significant difference between Jeuveau and other toxins is its concentration, and the accessory proteins are a part of the preparation. The potency of each neuromodulator is standardized in units. Jeuveau injections begin working as quickly as 2 days and last 3 to 4 months on average, with some patients experiencing superior duration, upwards of even 6 months.